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ABSTRACT
The FDA estimates that 35% of Americans
regularly consume aspartame,

an artificial sweetener used

in diet drinks and other sugar-free food items.

Some

anecdotal reports indicate the substance has been
associated with health, behavioral,
concerns.

and cognitive

The FDA and other regulatory agencies

indicate it is safe for use up to 50mg/kg/day.

They

further advise individuals with metabolic phenylalanine
disorders not to consume this product. This conflicting
advice has caused confusion for consumers and
practioners.

Therefore,

the purpose of this study was to

examine the effects of aspartame consumption on cognitive
functioning of healthy adults.
Orem's theory of Self-Care guided this descriptive,
clinical study. The effect of dietary aspartame
consumption on cognitive function of study participants
was monitored and analyzed for participants consuming
weighed food intakes for 16 days.
This study tested the hypothesis that cognitive

viii

functioning is poorer when participants'

dietary intake

of aspartame is higher. The sample population was
comprised of 180 randomly selected ethnically-diverse 18
to 40 year old healthy adults recruited through a
midwestern university.

Instruments used for measurement

included a Demographic Questionnaire, Weighed Food
Intakes,

Kearney and Fleischer's Exercise of Self-care

(alpha= .80), the Sternberg Item Recognition Test
=.95), and the Vandenberg Mental Rotation Test

(r

(KR-

20= . 88).
Depending on the cognitive task

(the Vandenberg

Mental Rotation Test), results indicated that cognitve
function was significantly better

(p=.03) when

participants consumed less aspartame
those who consumed more

(<1000mg/day)

than

(>1000mg/day).

The relevance of these results is that healthcare
professionals need to be aware of dietary factors that
can maximize cognitive function and promote quality of
life for their clients.

IX

CHAPTER I
INTRODUCTION AND REVIEW OP LITERATURE
A healthy lifestyle is essential for health promotion
and disease prevention. Proper dietary intake is one of
the key factors for living healthily. Although dietary
intakes have been well-recognized as a significant
contributor to "health," people do not pay much attention
to what they eat and "Americans consume much more sugar
than they need"

(Stadler & Essa, 2001, p.3) . According to

the Federal Continuing Survey of Food Intakes

(1994-1996),

the average American consumes an amount of sugar
substitutes equivalent to 20 teaspoons of sugar per day —
equal to about 80 grams of sugar (Henkel, 2004). The Food
and Drug Administration

(1987) estimates 35% of Americans

regularly consume aspartame, which is one of the most
widely-used sugar substitutes. Used as an artificial lowcalorie sweetener, aspartame has undergone numerous
studies regarding safety issues since its approval by the
FDA in 1981. Some anecdotal reports indicate aspartame
has been associated with health, behavioral,

and

cognitive function; and about two-thirds of these
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symptoms were neurobehavioral in nature
Stargel,

(Butchko &

2001). The FDA (2004) and other food regulatory

agencies indicate that aspartame may be safe for use up
to 50mg/kg/day. Based on this conflicting information,

it

seems important to determine what amount of aspartame
consumption would be considered safe for general use.
Purpose
The purpose of our study was to examine the effects
of aspartame consumption on cognitive function of healthy
adults,

testing the hypothesis that cognitive functioning

was poorer when participants'

dietary intakes of

aspartame were greater.
Significance of the Study
The effects of aspartame and its metabolic breakdown
products

(phenylalanine,

aspartic acid, and methanol)

have been investigated in general populations as well as
in subgroups. Along with these concerns,

rising safety

issues related to aspartame consumption have been
reported in studies,

such as the onset of brain tumors

and seizures, headaches,

allergies, behavioral changes,

and changes in cognitive function
Committee on Food

(European Scientific

[ESCF] , 2002) . Among these studies,

researchers have been increasingly paying attention to
the effects of aspartame on cognitive function. Over the

2

years,

it has been hypothesized that aspartame could have

an effect on human cognition

(Wurtman,

1985) . However,

a

number of studies show that there are no direct effects
indicated in tests by administrating single doses of up
to 60mg/kg/day

(Lieberman et a l , 1988; Lapierre et a l .,

1990; Pivonka & Grunewald,

1990; Stokes et al ., 1991;

Stokes et a l ., 1994).
Lapierre et a l . (1990) conducted a clinical study
among ten healthy adult volunteers with administration of
a single dose of aspartame

(15 mg/kg body weight in

capsules). Changes in mood, cognitive function,

and

memory were tested after aspartame administrations. The
researchers of this study reported that no detectable
differences were found between aspartame and placebo
despite of significant increases in plasma phenylalanine
levels after aspartame administration. Changes in mood
were also tested by Pivonka and Grunewald in young women
following aspartame-containing beverages consumption
(1990) . However,

Pivonka and Grunewald concluded that no

significant mood changes were observed following
aspartame consumption compared to water. Moreover,

the

effects of chronic aspartame consumption were also tested
among pilots by Stokes et a l . (1994). However, no
significantly declined cognitive performance observed
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among study participants following chronic dosing of
aspartame.
However,
debated,

the results of these studies can be

since single dosing administrations do not

reflect typical aspartame consumption patterns.
Consequently,

it suggests a more scientifically-designed,

well-controlled clinical study to further evaluate the
safe dosing issue.
This proposed study provided in-depth analysis of
the safety of aspartame consumptions among healthy adults
based upon more typical dietary intakes. Therefore,

it

was essential for individuals to consume food wisely and
in a manner considered to be "healthy."
Review of Literature
Aspartame's Role in the Diet
Aspartame,

a dipeptide

(L-aspartyl-L-phenylalaline

methyl ester) used as a nonsugar sweetener, was
discovered in 1965 and approved by the U.S. Food and Drug
Administration in 1981 as safe for use in a wide range of
food products. Today, aspartame is found in approximately
6000 products,

including soft drinks, chewing gums,

gelatins, puddings,

frozen desserts, yogurt, some

pharmaceutics, and many other products
Council, 2004).

(Calorie Control

It is chemically broken down into three
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metabolic components

(aspartic acid, phenylalanine,

methanol)

in the body by hydrolysis of intestinal

esterases

(American Dietetic Association,

and

1998) .

Since it was approved by the FDA in 1981, aspartame has
been used in thousands of products for more than 25
years,

and the amount of demand for aspartame use has

been increasingly rising from 8.4 million pounds in 1986
to 17.5 million pounds in 1992
Association,

(American Dietetic

1998) .

As it is increasingly being used as a generalpurpose sweetener,

aspartame has been harshly criticized

for its safety issues,
methanol toxicity;

including

(1) the possible

(2) the increased plasma

concentrations of phenylalanine and aspartic acid in the
brain;

(3) the potential neuroendocrine alterations

associated with elevated concentrations in the brain; and
(4) a hypothesized connection between aspartame and
epilepsy and brain malignancy

(ESCF, 2002) . These safety

issues related to aspartame and its breakdown metabolic
components have been studied in children and general
human populations

(ESCF, 2002) . Shortly after heavy

worldwide marketing of aspartame, numerous scientific
studies were conducted to investigate these safety issues
through clinical and laboratory research. According to
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the report by Calorie Control Council

(2004), aspartame

has been considered to be safe in more than 200 studies,
including studies by the U.S. Food and Drug
Administration

(FDA). However,

this investigator cannot

find the primary sources of the 200 studies stated above.
Despite the safety statement about aspartame by
regulatory agencies, however,

there were many anecdotal

reports of health effects related to aspartame
consumption

(Hull,

1999). In a report by the FDA (1995),

numerous consumer complaint reports were received and 11%
were considered serious. Given that 11% of the reports
were considered serious,

it seems there is a need for

further investigation.
Aspartame Consumption and Evidence of
No Significant Effects on Cognition
The increased recent interest in the safety of
aspartame has prompted investigators to explore whether
there is a link or not between aspartame consumption and
neurological effects as well as cognitive function.

It

has been hypothesized that aspartame might have the
potential for affecting neurotransmitter levels in the
brain since it is believed that a source of phenylalanine
from dietary consumption of aspartame -containing products
would increase phenylalanine concentrations in the brain.
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Wurtman

(1985)

further suggested that the increased level

of phenylalanine in the brain may disturb the balances in
monoaminergic neurotransmission,
effects on cognition, behavior,

thereby,

resulting in

and physiological

functions. The hypothesis has been tested in a number of
animal and clinical studies. Although effects on
neurotransmitter levels were noted based on some acute
and repeat-doses of administration at high doses in
animal studies, there were no statistically significant
and reproducible effects

(Dailey, et a l ., 1991; Reilly &

Laj tha, 1995) .
Furthermore,

Spiers et a l . (1998) conducted a

clinical research study to examine the aspartame effects
on neuropsychologic and neurophysiologic functioning.
Each study participant was administered one of three
treatments aspartame,

sucrose, or placebo. The authors

concluded that large daily doses of aspartame had no
effects on neuropsychologic,

neurophysiologic,

or

behavioral functioning in healthy young adults, and
stated that aspartame is safe for the general population
(Spiers et a l ., 1998). Another clinical study conducted
to measure the neuropsychiatric effects of aspartame
among healthy volunteers indicated that there were no
significant differences between aspartame and the placebo
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found in measures of sedation, hunger, headache,
reaction-time, cognition, or memory at any given time
during this study after ingestion of a single dose of
aspartame

(Lapierre et a l ., 1990).

Regardless of numerous negative research findings of
aspartame studies,

it is believed that there are still

some questionable issues left for further evaluation due
to a variety of anecdotal reports and debatable research
methodology

(Hull,

1999).

Aspartame Consumption and Evidence of
Significant Effects on Cognition
Although aspartame has shown little or no behavioral
effect in most studies,

Conners et a l . (1986)

stated that

activity observed following administration of sucrose or
fructose was less than after aspartame. Conners et a l .
(1986)

further reported that the improvement in attention

might be considered declined because of aspartame.
Another research study has also been conducted on
preschoolers who were treated with aspartame compared to
glucose,

sucrose,

administration,

and saccharin.

Following

their activities were observed

(Kruesi,

et a l ., 1985) . A significant decline of motor activity
was observed after aspartame administration, while other
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behavioral measures did not demonstrate significant
differences

(Kruesi, et a l .; 1985) .

Moreover,
(1984)

the U.S. Centers for Disease Control

reviewed 517 cases of consumer adverse reaction

complaint reports and concluded that 28% of the cases
showed adverse reactions,
mood changes,

such as headache,

dizziness,

insomnia, nausea and vomiting,

etc.,

occurred after aspartame-containing product consumption
(Butchko & Stargel, 2001) .
A recent study conducted in rats by Christian,

et

a l . (2004) reported that rats administered with aspartame
in the drinking water for three or four months showed a
significant increase in time when performing T-maze
activity.

Potts et a l . (1980) also reported that when

aspartame was administered as 9% of the diet for thirteen
weeks, altered learning behaviors were observed in male
ra t s .
Although there were no clinical studies to
demonstrate the effects of aspartame consumption on poor
neurobehavioral or cognitive function,

some anecdotal

reports have been presented to the FDA indicating adverse
reactions associated with potential effects of consuming
aspartame-containing products,

for example, headache,

dizziness, mood changes, nausea and vomiting,
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etc.

(FDA,

view of the studies'

conclusion discrepancies based on

industry- and non-industry-sponsored research
investigations,

a more thorough and well-controlled study

may be needed to generate a more scientific conclusion
for the use and safety of aspartame consumption.
Aspartame and Health Status
Although aspartame has been investigated for many
health-related problems,

there are not many studies done

in healthy adults related to their health status,

such as

physiological measures— respiration, pulse, blood
pressure, blood glucose, body weight, or temperature. One
laboratory study conducted by Kiritsy and Maher

(1986)

reported that animals with aspartame administration could
induce high blood pressure due to increased levels of
phenylalanine concentrations in the blood and brain.
Contrary to the findings of Kiritsy and Maher's study,
Leon et a l . (1989) concluded that there were no persistent
changes in vital signs

(including temperature,

respiration, blood pressure,

and pulse)

in participants

consuming aspartame for 24 weeks.
Theoretical Framework
Orem's Theory of Self-Care guided this descriptive,
clinical study. Our study examined the effects of
participants' aspartame consumption on the dependent
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variable,

that is, cognitive function. Orem's Theory of

Self-Care has been widely used in nutrition studies
(Owasoyo, et a l , 1992; Lindseth and Lindseth,

1995). Self-

care is defined as a significant factor for maintaining a
high quality of life. Self-care agency is the capability
of allowing patients to distinguish factors that need to
be controlled to facilitate better regulation of their
functioning and development

(Orem, 1995). Self-care

involves use of knowledge in order to promote health and a
high-quality of life. Since self-care is a learned, goaloriented activity,

it was thus measured in our study to

determine each participant's capabilities and determine
the effectiveness of dietary changes intended to promote
management of people's functioning and quality of life.
Research Questions
1. To what extent was cognitive function affected by
higher aspartame consumption

(a 1000 mg/day)

from dietary intake in comparison with lower dietary
aspartame consumption

(< 1000 mg/day)?

2. What was the relationship among cognitive function
scores, dietary aspartame consumption,

demographics,

and health status in healthy participants?
Definitions
The definitions were used in the study as follows:
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1995). This indicates a demand for further investigation
for its safe use.
Discrepancies among Studies
The European Scientific Committee on Food

(ESCF)

concluded that here were no significant effects of
aspartame consumption noted on behavior, mood, or EEG
profiles,

or cognitive function,

even with elevated

phenylalanine levels in the brain in long- and short-term
clinical studies in either the general populations or
sensitive individuals
studies,

(2002). However,

an analysis of 164

including 90 non-industry-sponsored and 74

industry-sponsored studies,

reviewed by Ralph Walton,

Chairman of The Center for Behavioral Medicine and
Professor of Clinical Psychiatry at Northeastern Ohio
Universities College of Medicine,

concluded that there

were many questions left related to human safety. Of
these 164 studies,
studies,

among 90 non-industry-sponsored

92% found one or more problems associated with

aspartame. Among 74 industry-sponsored studies,
stated that there were no problems found
Toxicity Information Center,

100%

(Aspartame

1996) . However,

this

investigator was not able to evaluate these one hundred
sixty-four studies as mentioned above due to the lack of
available primary sources reviewed in Walton's report.
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In

Cognitive function was defined as enabling users "to
transform a (prescribed)

task into an activity

(effective

task)" and was "experimentally elicited by interpreting
the deviations between the task and user activity in
terms of role, context,

and resources"

(Boy, 1998, p.

266-267). These resources included user-based
knowledge and skills)
functions

(Boy,

and task-based

(e.g.,

(e.g., procedures)

1998). Cognitive function was

operationally measured for our study using the Vandenberg
Mental Rotation Test

(MRT) and Sternberg Item Recognition

(SIR) Test.
Vandenberg Mental Rotation Test presented
participants with a series of problems in which they were
given a geometric figure as a target item and a row of
four geometric figures as distracters, and the task was to
select two of the four distracter items which is the same
as the target items. The participants needed to complete
20 questions within 6 minutes to earn a maximum score of
40 on the test. MRT had a score of Kuder - Richardson
internal consistency .88 and a test-retest reliability .83
when tested for reliability (Vandenberg & Kuse, 1978).
Sternberg Item Recognition Test was used to test
short term memory. For this test, a computer was used to
present stimuli on a monitor and participants were given a
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short list of items

(typically digits), and they responded

to each trial as quickly as they could, and the computer
recorded their responses for approximately ten
milliseconds. The coefficient for test-retest reliability
for SIR test was a .95 (Sternberg, 1966) .
Assumptions
1. Individuals might not have been aware of how much
aspartame they consumed in their daily lives since
aspartame is increasingly used in almost 6,000
products.
Limitations
1. This is a secondary analysis. Therefore,

this

investigator had no control of variables because data
was collected after participants'

dietary intakes.

2. This is a secondary analysis. Therefore,

this

investigator had no control of the study groups and
control group since all data was gathered after
dietary treatments.
Summary
Although a number of studies showed that there was
little or no direct effects of aspartame consumption on
neurobehavioral or cognitive function, as discussed
above,

the question is still left to be discussed further

due to the debatable study methodology and the
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credibility of study conclusions. Further study needs to
test consumer reported adverse reactions associated with
aspartame consumption since some study results are still
controversial. Overall,

the purpose of the study was to

examine the effects of aspartame consumption on the
cognitive function of healthy adults.
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CHAPTER II
METHODOLOGY
Introduction
The purpose of our study was to examine the effects
of aspartame consumption on cognitive function of healthy
adults,

testing the hypothesis that the cognitive

functioning was poorer when participants'

consumption of

dietary aspartame intakes were greater.
This chapter focuses on the methodology employed in
our study. The study population,

sample,

data collection methods and procedures,

study design,
instrument

reliability and validity, data analysis,

and the

protection of human subjects are addressed in this
chapter.
The research questions of our study were the
following:
1. To what extent was cognitive function affected by
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison with lower dietary
aspartame consumption

(< 1000 mg/day)?

2. What was the relationship among cognitive function
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scores, dietary aspartame consumption,

demographics,

and health status in healthy participants?
Population and Sample
The sample population was comprised of 180 randomly
selected ethnically-diverse 18 to 40 year-old healthy
adults recruited through a midwestern university. The
criteria for inclusion were as follows:
of age;

(a) 18 to 40 years

(b) capacity to read, understand, and speak

English; and (c) enrollment in a midwestern university.
Study Design
Orem's Theory of Self-Care guided this clinical study
using a descriptive,

correlational study design. Each

participant served as his or her own control when
participating in the study. Amounts of aspartame
consumption by each participant were calculated by a
registered dietitian based upon the amount of aspartame
contained in food products provided by the manufacturers.
The data were recorded and analyzed from weighed food
intakes for 16 days for comparison of cognitive testing
mean scores on aspartame consumption.
Data Collection Methods/Procedures
This is a secondary analysis based upon the
following clinical study which included food treatments.
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A registered dietitian and the study investigators
were consulted about the dietary treatments. The purpose
and details of the study were explained to the
anticipating participants at an arranged meeting and
questions were also answered by the researchers.
Participants who signed the study consent forms completed
questionnaires and had measurements taken for
demographics,

self-care agency, and anthropometries.

Participants were randomly selected for the study. The
participants met with the research team a week before
treatments. On the treatment weeks, each participant was
instructed to consume only the food and beverages provided
for the study; moreover,

the participants were instructed

to complete questionnaires on a daily basis about that
food consumption. The importance of compliance with the
treatment plan was also addressed.
Dietary intakes were controlled in terms of what
and how much was consumed. On the weeks of treatment,

a

weighed scheduled meal was given to each participant for
16 days

(three 4 -day dietary treatments). A weighed food

record was well-recognized as the most precise method for
measuring individuals'

food intakes according to Gibson

(1990). Food portions were measured based upon
individuals'

kilocalories per day using indirect metabolic
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calorimetry, and portion sizes were weighed before and
after consumption. Beverages,

such as juices and milk,

were given to the participants with no limited amount as
part of their meals. The participants' preferences of
beverages were taken into account for their daily caloric
intakes. However, only water and non-caloric drinks in
addition to fluids provided at meals were issued and the
amount of caffeine was carefully controlled in the study
because of its potential effects on cognitive function
with no more than 200 mg per day. Snacks were also issued
to participants to take home for consumption between the
evening meal and before midnight.
Meals were brought by the researchers or research
assistants directly to each participant and served in a
private study dining room at the university. Food
preparation was completed with the consultation and under
the guidance of a dietitian, and the researchers or
research assistants confirmed that each meal was prepared
properly before serving the participants. Amounts of
aspartame were mainly analyzed for its potential effects
on cognitive function.
Instrumentation and Reliability & Validity
This is a secondary analysis of the clinical study "Nutritional Effects on Cognition and Flight Performance."
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Demographics. A Demographic Questionnaire was
completed by each participant,
residence, age

including place of

(in years), education (in years),

marital/social living status, employment status, and
ethnic identification.
Anthropometric measurements. Serial weights and
weight-for-height measures were recorded,
indices

and body mass

(BMI) were further calculated for each

participant. The components of reliability for
anthropometric measures were studied in both male and
female participants from the Second National Health and
Nutrition Examination Survey (NHANES II). The
anthropometric measurements for our study (weight and
height) had reliabilities greater than 0.97

(Marks, et

a l ., 1989) . Body weights were taken twice for each
participant using a Cardinal-Detecto balance beam scale,
at the beginning and at the end of each study week. Height
was measured and recorded on the first visit by using an
Accu-stat wall-mounted height board. BMIs, a ratio of
weight for height based upon the measurement of each
participant on admission, were calculated in accordance
with the Quatelet Index (kg/m2) (Gibson,

1990) . In

addition, serial weight was monitored to determine if the
participant was considered underweight or overweight at
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the beginning of the study and as a baseline for
monitoring weight gains or losses during the study.
Health assessment data. The data of health status
assessment modified from Doenge's Health Assessment
Checklist

(1989) was collected and recorded for each

participant. The checklist consisted of nine factors,
including history of chronic systemic disease such as
heart disease, hypertension,

respiratory insufficiency,

diabetes; metabolic or GI disorders; and urinary or
neurological disorders. To control for these disorders,
data were eliminated if disorders from these systems are
an interfering factor.
Dietary treatments. Weighed food intakes were used to
calculate each participant's dietary aspartame intakes
from their meals, by using the Food Processor-Genesis
System to analyze a variety of extensive nutrients based
on the U.S. RDA. Indirect calorimetry was used to
determine the appropriate calorie levels, rather than BMI
and activity levels. Confounding relationships between
food process and food borne illnesses were controlled
through closely monitored food distribution practices.
Self-care agency. Self-care agency was measured to
determine the participants'

abilities to take care of

themselves with the reliability of Kearney and Fleischer's
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Exercise of Self-Care Agency

(alpha = .80)

(Whetstone,

1986) .
Cognitive Function Tests. Two psychometric measures,
the MRT and the SIR test, were used to assess
participants'

cognitive functions. The MRT instrument

presented participants with a series of problems in which
they were given a geometric figure as a target item and a
row of four geometric figures as distracters,

and the

task was to select two of the four distracter items which
were the same as the target items. The participants
needed to complete 20 questions within 6 minutes with a
maximum score of 40 on the test. A Kruder-Richardson
internal consistency coefficient was

.88 when testing

reliability of the Vandenberg Test of Mental Rotation
(Vandenberg & Kurse,

1978). The SIR test was used to test

short term memory. For this test, a computer was used to
present stimuli on a monitor and participants were given
a short list of items

(typically digits), and they

responded to each trial as quickly as they could,

and the

computer recorded their responses for approximately ten
milliseconds. The coefficient of test-retest reliability
for short term memory testing was > .95
1966) .
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(Sternberg,

Data Analysis
The study data was analyzed by using the Statistical
Package for Social Science
Procedure

(SPSS) . The SPSS Explore

(2006) was utilized to screen data and to test

for normality and homogeneity of variance. Demographic
data was analyzed in our study in regards to each study
participant,

including the following:

years of education received;

(a) the age;

(2) the

(c) the body mass index;

(d)

the self-care agency score. The frequencies were evaluated
for responses to the measures of dietary aspartame
intakes, demographics,

health status,

and cognitive

function. These data were analyzed by descriptive and
inferential statistics. An alpha level of .05 was the
criterion for significance.
Descriptive statistics and correlations were used to
analyze the effects of dietary aspartame consumption by
the participants when comparing their cognitive function
levels during treatment measures. All data were
quantified for analysis. Our study was conducted in
accordance with the methods discussed above to examine
the effects of aspartame consumption on cognitive
function by using the descriptive and correlational
statistics.
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Protection of Human Subjects
The Institutional Review Boards of the university and
the U.S. Army Biomedical Research Human Use Committee
reviewed and approved the study regarding ethical
considerations for the human subjects in the study. The
researchers of our study also clearly explained to
participants that the study was totally voluntary and all
collected data will remain confidential and only the
summative and collective results will be reported. Each
participant was also assured that there was no way in
which she/he could be identified.
The findings of our study would help healthcare
professionals as well as each individual in the society to
better understand the dietary aspartame consumption. This
information would benefit both healthcare providers and
the consumers as well.
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CHAPTER III
DEMOGRAPHICS
Introduction
The purpose of our study was to examine the effects
of aspartame consumption on cognitive function of healthy
adults,

testing the hypothesis that the cognitive

functioning was poorer when participants'

dietary intakes

of aspartame were greater.
This chapter focuses on the demographic
characteristics of the sample used in our study.
The research questions of our study were the
following:
1. To what extent was cognitive function affected by
higher aspartame consumption

(> 1000 mg/day)

from dietary intake in comparison with lower dietary
aspartame consumption

(< 1000 mg/day)?

2. What was the relationship among cognitive function
scores, dietary aspartame consumption,

demographics,

and health status in healthy participants?
The Statistical Package for the Social Sciences
(SPSS) program was utilized to analyze the result
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obtained in our study, and significance was set at the
.05 level.
Demographic Characteristics
Demographic data were analyzed in our study in
regards to each participant as follows:
the years of education received;

(a) the age;

(2)

(c) the body mass index;

(d) the self-care agency score. Ages of the study
participants ranged from 18 to 40 years old. The analysis
of the demographic characteristics of the study
participants revealed that the mean age was 20.6 years
with a standard deviation of 2.0. The average education
years of the study participants was 13.6, and the standard
deviation of education years was .98. The mean body mass
index of the participants was 24.8 with a standard
deviation of 3.5. The self-care agency mean scores of the
study participants were 127.2, and the standard deviation
was 13.7. These demographic data are illustrated in Table
1.
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Table 1
Means and Standard Deviations for Demographics, Health
Status, and Self-Care Agency Data

(n=176)
SD

Variable

Mean

Demographics of the sample
20.6

2.0

13.6

.98

Body Mass Index (BMI)

24.8

3.5

Self-care Agency (Scores)

127.2

13.7

Age

(Years)

Education (Years)
Health Status of the Participants
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CHAPTER IV
RESULTS AND ANALYSIS
Introduction
The purpose of our study was to examine the effects
of aspartame consumption on cognitive function of healthy
adults,

testing the hypothesis that the cognitive

functioning was poorer when participants'

dietary intakes

of aspartame were greater.
This chapter discusses the statistical analysis used
and results obtained in our study.
The research questions of our study were the
following:
1. To what extent was cognitive function affected by
higher aspartame consumption

(> 1000 mg/day)

from dietary intake in comparison with lower dietary
aspartame consumption

(< 1000 mg/day)?

2. What was the relationship among cognitive function
scores,

dietary aspartame consumption,

demographics,

and health status in healthy participants?
The Statistical Package for the Social Sciences
(SPSS) program was utilized to analyze the results

28

obtained in our study and significance was set at the .05
level.
Research Question 1
The first research question was to examine to what
extent cognitive function was affected by higher
aspartame consumption

(> 1000 mg/day)

from dietary intake

in comparison with lower dietary aspartame consumption

(<

1000 mg/day).
Of 180 study participants,

95 consumed aspartame

equal to or greater than 1000 mg per day, and 78 consumed
aspartame less than 1000 mg per day from their dietary
intakes. Table 2 shows the amount of aspartame contained
in some common products and its toxicity levels based on
50mg/kg/d = toxic.
Vandenberg Mental Rotation Test Mean Scores and
Aspartame Consumption
The MRT score differences of the participants were
compared for aspartame consumption. The MRT scores were
based upon measures of dietary aspartame intakes. The mean
MRT cognition score of study participants who consumed
aspartame equal to or greater than 1000 mg per day was
14.8 with a standard deviation of 6.0, and the mean MRT
score of study participants who consumed aspartame less
than 1000 mg per day was 16.7 with a standard deviation of
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5.6. With the MRT measure, a higher score indicates better
cognitive performance.
Statistically significant differences for Table 3
were based upon an analysis of the amount of aspartame
consumption from food. The MRT scores were significantly
different with mean scores of 14.8

(±6.0)

and p=.03 when

aspartame consumption equal to or greater than 1000 mg per
day. The mean scores of cognitive measures are shown in
Table 3, which illustrates between-subjects differences
for the dietary aspartame intakes of the participants when
using t-test analysis.
Table 2
Aspartame Equivalents

Aspartame Equivalents(lOOOmg)

Servings 54.5kg Female FDA defined toxicity *

Carbonated drinks (12 oz)

5.56

15.15

Yogurt (8 oz)

8.06

21.99

Powdered soft drinks(12 oz)

8.33

22.73

Gelatin dessert (4 oz)

10.53

28.71

Fruit drinks - 10% fruit juice

14.29

38.96

Ice cream (4 oz)

20.00

54 .55

Pudding (4 oz)

40.00

109.09

Chewing gum - 1 stick

142.86

389.61

Vitamins - 1 Multivitamin

250.00

681.82

Breath mints - 1 mint

666.67

1,818.18

*Based on 50 mg/kg/d = Toxic
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Sternberg Item Recognition Mean Scores and
Aspartame Consumption
T-test analysis was utilized to examine the SIR
score differences of study participants for their dietary
aspartame consumptions. Mean SIR scores were 731.9

(±

190.5) when aspartame consumption was equal to or greater
than 1000 mg per day compared to 730.9

(±144.0) while

aspartame consumption was less than 1000 mg per day. The
SIR scores were based on measures of aspartame intakes
from food. The between-subjects differences for the
dietary aspartame intakes of the participants were
analyzed by using a t-test. T-test analysis of effects of
aspartame consumption showed no significant differences in
scores using the SIR test as illustrated in Table 4.
Table 3
Comparison of MRT Mean Scores and Aspartame Consumption
Variable

Aspartame

Aspartame

< 1000 mg/day

> 1000 mg/day

Mean

SD

Mean

SD

14.8

6.0

t

p

2.13

.03

Cognitive Measures
Vandenberg Mental

16.7

5.6

Rotation Scores
NS
Significance*: p = < .05
n= 169
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Table 4
Comparison of SIR Test Mean Scores and Aspartame
Consumption
Variable

Aspartame

Aspartame

< 1000 mg/day

> 1000 mg/day

Mean

SD

Mean

SD

730.9

144.0

731.9

190.5 .04 NS

t

P

Cognitive Measures
Sternberg Item
Recognition Scores

NS
Significance*: p= <.05
n= 16 9
Research Question 2
The second question examined by our study was what
the relationship among cognitive function scores, dietary
aspartame consumption,

demographics,

and health status in

healthy participants was.
Pearson's Correlations were used to examine this
relationship. Based upon Pearson Correlations, no
significantly correlated relationships were indicated
among dietary aspartame consumption and body weight,
blood pressure,

respirations, body temperature,

self-care agency and the SIR test; however,

glucose,

it shows that

aspartame was inversely correlated with the M R T . The MRT
also had an inversely correlated relationship with the
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SIR test. The self-care agency scores also inversely
correlated with the participants'
respiration,

body weight,

measures for

SIR scores,

and MRT scores.

Table 5 shows some significant intercorrelational
variables for healthy adults in our study.
Table 5
Intercorrelations of Effects of Aspartame Consumption on
Cognitive Function Scores with Demographic and Health
Status Variables

Effects of Aspartame Consumption op Physiological Changes
Physiological measures

(respiration and pulse)

of

the study participants were also compared for differences
based on aspartame consumptions. The respiration scores
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were significantly different

(p = .04) when comparing

aspartame consumption equal to or greater than 1000 mg per
day, which had a mean score of 22.4

(+ 15.96), to

aspartame consumption less than 1000 mg per day, which had
a mean score of 18.6

(± 6.95). However, T-test analysis

did not find significant effects of aspartame consumption
on pulse measure as indicated in Table 6.
Table 6
Comparison of Physiological Changes Mean Scores and
Aspartame Consumption
Variable

Aspartame

Aspartame

< 1000 mg/day

> 1000 mg/day

Mean

SD

Mean

SD

t

P

Physiological Measures
Respiration

18.6

6.95

22.4

15.96

2.05

.04

Pulse

82.8

14.7

82.1

14.99

.32

NS

NS
Significance*: p= <.05
n= 169
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CHAPTER V
DISCUSSION,

CONCLUSIONS, AND RECOMMENDATIONS
Introduction

The purpose of our study was to examine the effects
of aspartame consumption on cognitive function of healthy
adults,

testing the hypothesis that cognitive function

was poorer when participants'

dietary intakes of

aspartame were greater.
This chapter briefly summarizes study results
followed by a discussion and then a section on study
conclusions. Recommendations for education, practice,

and

research suggested by our study are also given.
The research questions of our study were the
following:
1. To what extent was cognitive function affected by
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison to lower dietary
aspartame consumption

(< 1000 mg/day)?

2. What was the relationship among cognitive function
scores, dietary aspartame consumption,

demographics,

and health status in healthy participants?
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Summary
Our study examined the effects of dietary aspartame
consumption among study participants.

It also tested the

statistical relationships among cognitive function
scores, dietary aspartame consumptions,

demographics,

and

health status. The MRT and the SIR test were used to
assess the extent to which cognitive function scores were
affected by dietary aspartame consumption of study
participants.
180 subjects participated in our study. Of these
participants,

95 consumed dietary aspartame intakes equal

to or greater than 1000 mg per day, and 78 consumed less
than 1000 mg per day.
T-test analysis found statistically significant
differences

( t = 2.13, p =.03)in the MRT scores among

participants who consumed equal to or more than 1000 mg
of aspartame per day in their diet when compared to
participants who consumed less than 1000 mg per day. A ttest analysis did not find statistically significant
differences in the SIR scores among study participants
who consumed equal to or more than 1000 mg per day in
their diet when compared to participants who consumed
less than 1000 mg per day.
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Pearson's Correlations were used to examine the
relationships among cognitive function scores,
consumption,

demographics,

aspartame

and health status in healthy

participants. Using the Pearson's correlation
coeffecient,
MRT

aspartame correlated significantly with the

(r = -.18, p = .05), which negatively correlated with

the SIR test; however,

a significant correlation between

the SIR test with dietary aspartame consumption was not
indicated. A Pearson's correlation test did not indicate
significant relationships among dietary aspartame
consumptions, body weight, blood pressure,
body temperature,

serum glucose,

respiration,

and self-care agency.

Dorothea Orem's Self-care Deficit Theory was used as
the theoretical framework to guide this clinical study.
Lack of knowledge about healthy dietary consumption is
viewed as a self-care deficit. Therefore,

healthcare

professionals could help people overcome this deficit by
providing appropriate education about healthy diets as
well as healthier lifestyles.
Discussion
A major finding of this clinical study showed
significant differences in cognitive function when
comparing higher dietary aspartame consumption to lower
dietary aspartame consumption using the MRT. This finding
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seems to reflect an earlier hypothesis that aspartame
might have the potential for affecting neurotransmitter
levels in the brain since it is believed that dietary
consumption of aspartame-containing products could
increase phenylalanine concentrations in the brain
(Wurtman,

1985). Wurtman

(1985)

further suggested that

the increased level of phenylalanine in the brain may
have an impact on the balances in monoaminergic
neurotransmission,

consequently resulting in effects on

cognition, behavior,

and physiological function. The

hypothesis was tested in a number of animal and clinical
studies.
Similar to the results of our study using the MRT, a
recent study conducted in rats by Christian et a l . (2004)
found that rats treated with aspartame

(250mg/kg/day)

in

the drinking water for three or four months showed a
significant increase in time when doing T-maze
performance. This may suggest a possible effect of long
term aspartame consumption on memory. However,

the

finding of this animal study did not reflect the results
of the SIR test in our study.

In addition,

altered

learning behaviors were found in male rats with aspartame
administration as 9% of the diet for thirteen weeks
(Potts et a l ., 1980).
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One study reported that when observing children's
activities following administration of 1.25mg/kg of
sucrose or fructose activities were less than after
aspartame consumption

(Conners et a l ., 1986).

It appears

that aspartame might play a major role in increasing
children's activity if the sugars are considered
reference points. The researchers of this study further
reported an improvement in attention among children with
the sugars compared to the subgroup of thirteen children
with aspartame administration. Conners et a l ., therefore,
suggested that aspartame might be claimed to cause the
decline in attention activity.
Another study has also been conducted on 32
preschoolers with administration of 30mg/kg of aspartame,
were observed in comparison with glucose,
saccharin

sucrose,

and

(Kruesi, et a l ., 1985) . When activity was

observed in these children,

a decline in motor activity,

considered significantly less active in these
preschoolers, was noted after aspartame administration,
while other behavioral measures did not show significant
differences
study,

(Kruesi, et a l ., 1985). The authors of this

therefore,

concluded that the behavioral effects

of acute aspartame consumption,

if present, were viewed

as subtle. They further pointed out that children
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considered relatively "slowing down" following aspartame
consumption had higher "internalizing" scores on the 11
Achenbach Child Behavior Checklist than children without
"slowing down" did.
It is interesting to note that in our study the SIR
test did not confirm Wurtman's hypothesis. The score
differences of our study participants were compared for
aspartame consumption; however, there were no significant
effects of aspartame consumption on the SIR test. This
finding concurs with the result of a clinical research
study conducted by Spiers et a l . (1998). Forty-eight
volunteers participated in the study, and each
participant was treated with one of three treatments of
aspartame,

sucrose,

or placebo. The authors concluded

that large daily doses of aspartame had no significant
effects on neuropsychologic, neurophysiologic,
behavioral functions in healthy young adults,

or
although

plasma phenylalanine concentrations were increased during
aspartame treatment

(Spiers et a l ., 1998).

This finding is also consistent with the results of
a research study by Lapierre et a l . (1990).

In this

study, the neuropsychiatric effects of aspartame were
monitored among ten healthy volunteers using visual
analog scales,

arithmetic test score, and brake-pedal
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reaction timer measures. The study results indicated that
there were no significant differences between aspartame
and the placebo detected in measures of reaction-time,
cognition,

or memory at any time during the study

following a single dose of aspartame ingestion

(Lapierre

et a l ., 1990). Similar results were also reflected in
other clinical investigations.

For example,

in one study,

thirteen pilots were tested by using SPARTANS cognitive
test. The authors reported that aspartame ingestion was
not detrimental to impairment in skills essential for
cognitive performance,

and that performance was not

degraded to any measurable degree

(Stokes et a l ., 1991) .

A number of research studies were also carried out
on children and potentially sensitive individuals to test
whether aspartame consumption was related to cognitive
and behavioral changes.
depression,

Individuals diagnosed with PKU,

Parkinson's disease, Attention Deficit

Disorder(ADD), epilepsy or other suspected seizures were
studied. There were no effects observed in children
regarding behavior, mood, or learning when aspartame was
consumed at a single dose and multiple doses for up to
two weeks
However,

(Saravis, et a l ., 1990; Shaywitz et a l ., 1994).
individuals with PKU must be restricted in their

phenylalanine intakes from all food resources,
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including

aspartame

(Butchko & Stargel,

2001). The FDA (2004)

further advises these individuals not to consume this
product.
Treatment-related longer-term effects were also not
noted in children with ADD

(Shaywitz et a l ., 1994) . The

same results were also indicated in a study of preschool
children described as sugar sensitive by their parents
(Wolraich,

et a l ., 1994).Although effects on

neurotransmitter levels were noted based on some single
and repeat-doses of aspartame administration at high dose
levels in animal studies, Dailey et a l . (1991) and Reilly
and Lajtha

(1995)

stated there were no statistically

significant and reproducible effects.

Similar results

were also reported in studies with administration of
single doses of up to 60mg/kg/day

(Lieberman et a l , 1988;

Lapierre et a l ., 1990; Pivonka & Grunewald,

1990; Stokes

et a l ., 1991; Stokes et a l ., 1994). The results of these
studies can be debated, however,

since single dosing

administrations do not reflect chronic aspartame
consumption.
Using correlational coefficients,

there were no

correlational relationships among dietary aspartame
consumption,

health status, and physiological measures,

such as body temperature, weight, blood pressure,
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respirations,

and random glucose. Although in our study a

significant relationship between dietary aspartame
consumption and body physiological changes such as blood
pressure and body temperature was not indicated,
conducted by Kiritsy and Manor

a study

(1986) concluded that the

neurochemical changes produced by aspartame could lead to
significant changes in blood pressure.
study on rats, Kiritsy and Maher

In this laboratory

(1986) reported that

animals receiving aspartame injections could induce
hypertension because of increased levels of phenylalanine
in the blood and brain. They further pointed out that
elevated levels of phenylalanine could be hydrolyzed to
tyrosin in the liver, which can lead to blood pressure
changes.
In our study, physiological measures

(respiration

and pulse) were compared for differences between
participants who consumed dietary aspartame intakes of
equal to or more than 1000 mg per day and who consumed
less than 1000 mg per day in our study. There were
statistically significant differences

(p=.04) in the mean

respiration scores when comparing the two groups. This
finding is not consistent with the results of the study
by Leon et a l . (1989), who concluded that there were no
persistent changes in vital signs
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(including temperature,

respiration, blood pressure,

and pulse)

in participants

consuming aspartame for 24 weeks. No significant
differences were found when measuring the effects of
dietary aspartame consumption on pulse in our study of
healthy adults. Yet, over 1% of all claims reported to the
FDA were consequential respiratory symptoms associated
with aspartame consumption.

It is believed that aspartame

could have an impact on certain neurotransmitters in the
brain which influence the respiratory center
Consumer Safety Network,

(Aspartame

1996).

Another interesting finding of our study was that
Self-care Agency had significantly inverse correlation
with respiration, body weight,
As described by Orem

the SIR test and the M R T .

(1995), self-care agency was an

acquired ability to meet an individual's needs of self
care. Orem (1995)

further pointed out that the capability

of doing self-care was determined by individuals when
they were engaged in activities. Due to limited research
study references in the literature,

it is recommended

that further study may be considered when investigating
the potential impact of self-care agency on human beings'
capability of performing activities in their daily lives.
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Conclusions
To summarize,

the findings of our study seem to

support the hypothesis that aspartame may be related to
cognitive function as evidenced by aspartame consumption
equal to or greater than 1000 mg per day based upon the
M R T . However,

these findings are preliminary,

and much

work needs to be done to further substantiate the results
of our study. Given all of the above and our own
findings, however, we are skeptical about reports that
aspartame may be related to neuropsychological and
neurologic symptoms.

Further investigations are necessary

to clarify this important issue.
It seems that a large amount of aspartame
consumption might have an impact on human being's
cognitive function in the long-run. Healthcare
professionals should assist people to overcome a selfcare deficit and allow them to further establish
healthier self-care activities.
Recommendations
Recommendations were made for practice,

education,

and research based upon the results obtained in this
clinical study.

45

Practice and Education
Information provided by our study will help to
increase healthcare professionals'

knowledge base about

the role of the artificial sweetener -- aspartame in
common food products. Because of increasing use of
aspartame in food products,

it will be beneficial to

educate individuals regarding the potential risks for
health problems and potential benefits for eating
healthier. Although debate on aspartame products has been
controversial for many years,

it may still be possible

that individuals might not be aware of potential risks
related to large amount of aspartame consumption.
Our study found that the large amount of aspartame
consumption

(equal to or greater than 1000 mg per day)

significantly decreased individuals'

abilities to perform

on the M R T . Although the results were not statistically
significant on the SIR test,

it still poses a caution

about what people eat. These study findings suggest that
people should be aware of the amount of aspartame
consumption in daily food intakes,
1000 mg per day,

especially less than

since people could easily drink five or

six cans of carbonated drinks per day without noticing,
which approximately equal to 1000 mg of aspartame. These
issues are also education related since knowledge of
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research findings should be translated to clinical
practice and public healthcare education.

Therefore,

without research findings translated from the "bench to
bedside," clinical practice cannot be modified to provide
high-quality care for people.
Research
In conducting our study, several areas of further
research were suggested. Healthcare professionals should
be aware of new research findings related to practice and
education in order to provide more thorough and current
knowledge to people. As healthcare providers, we also
need to utilize Orem's Theory to assist people to meet
their self-care demands.
Recommendations for further research include the
following:
1. Replication of our study with tighter control of
variables,

such as participants with and without

long-term dietary aspartame consumption.
2. Replication of our study involving more diverse
population samples,

such as including the elderly

and the adolescent population.
4. A study comparing control group, placebo group,
and treatment group on the consumption of
aspartame food products.

5. Replication of our study following study
participants'

cognitive function for a longer

period of time.
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